India’s Pharma Exports Face High Risk Amid US Tariff
India’s pharmaceutical sector is staring at heightened uncertainty following US President Donald Trump’s recent increased tariff on Indian goods. On…
Biocon
Read More
The rising obesity epidemic in India
Overweight and obesity are becoming more and more common in India, affecting not only adults but also youngsters. The regional…
Biocon Requests Government to Exempt Cancer and Rare Disease Drugs from Tax in Upcoming Budget
Ahead of India’s upcoming budget announcement, Biocon’s Chairperson Kiran Mazumdar Shaw has called for the elimination of taxes on drugs…